Applications of Gold Nanoparticles in Brain Diseases across the Blood-Brain Barrier

被引:4
作者
Zhang, Jun [1 ]
Yang, Ting [1 ]
Huang, Wan [1 ]
Yu, Yao [1 ]
Sun, Taolei [1 ]
机构
[1] Wuhan Univ Technol, Sch Chem Chem Engn & Life Sci, Wuhan 430070, Peoples R China
基金
中国国家自然科学基金;
关键词
Blood-brain barrier; gold nanoparticles; brain diseases; drug delivery; Alzheimer's disease; brain tumors; BETA-AMYLOID PEPTIDES; DRUG-DELIVERY; TRANSFERRIN RECEPTOR; TARGETED NANOPARTICLES; FOCUSED ULTRASOUND; PARTICLE-SIZE; CNS DELIVERY; BIODISTRIBUTION; DOXORUBICIN; CROSS;
D O I
10.2174/0929867329666220527121943
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Brain diseases, including Alzheimer's disease (AD), brain tumors and Parkinson's disease (PD), pose heavy pressure on the public healthcare system. The main obstacle to vanquish brain diseases is the blood-brain barrier (BBB), which is a selective barrier mainly formed by brain endothelial cells. BBB prevents almost all drugs from reaching the brain, thereby hindering drug delivery. Over the past few decades, considerable signs of progress have been made in crossing the BBB and treating brain diseases. Gold nanoparticles (AuNPs) demonstrate the characteristics of adjustable size, unique optical properties, flexible surface modification, and good biocompatibility, which all contribute AuNPs as a promising candidate in biomedical fields. This article reviews the structure and properties of BBB, and discusses main transport routes through the BBB. Besides, nanoparticles, specially AuNPs applied in brain diseases as main drug delivery platforms, are systematically summarized, emphasizing several methods to modify AuNPs, including tuning particle size and surface modification, which are aimed at promoting BBB penetration or prolonging circulation time of AuNPs. In addition, AuNPs utilized in brain diseases are introduced in detail from the aspects of brain imaging, AD, brain tumors, and PD. Prospects and challenges that need to be considered in further investigations and clinical transformation of AuNPs used in brain diseases are also included, hoping to bring new insights into the applications of AuNPs in brain diseases.
引用
收藏
页码:6063 / 6083
页数:21
相关论文
共 108 条
  • [1] Structure and function of the blood-brain barrier
    Abbott, N. Joan
    Patabendige, Adjanie A. K.
    Dolman, Diana E. M.
    Yusof, Siti R.
    Begley, David J.
    [J]. NEUROBIOLOGY OF DISEASE, 2010, 37 (01) : 13 - 25
  • [2] Recent strategies and advances in the fabrication of nano lipid carriers and their application towards brain targeting
    Agrawal, Mukta
    Saraf, Swarnlata
    Saraf, Shailendra
    Dubey, Sunil Kumar
    Puri, Anu
    Patel, Ravish J.
    Ajazuddina
    Ravichandiran, V.
    Murty, Upadhyayula Suryanarayana
    Alexander, Amit
    [J]. JOURNAL OF CONTROLLED RELEASE, 2020, 321 : 372 - 415
  • [3] Anthocyanin-Loaded PEG-Gold Nanoparticles Enhanced the Neuroprotection of Anthocyanins in an Aβ1-42 Mouse Model of Alzheimer's Disease
    Ali, Tahir
    Kim, Min Ju
    Rehman, Shafiq Ur
    Ahmad, Ashfaq
    Kim, Myeong Ok
    [J]. MOLECULAR NEUROBIOLOGY, 2017, 54 (08) : 6490 - 6506
  • [4] Alzheimer's Australia, 2014, Alzheimer's Dementia 2014
  • [5] Novel Curcumin loaded nanoparticles engineered for Blood-Brain Barrier crossing and able to disrupt Abeta aggregates
    Barbara, Ruozi
    Belletti, Daniela
    Pederzoli, Francesca
    Masoni, Martina
    Keller, Johannes
    Ballestrazzi, Antonio
    Vandelli, Maria Angela
    Tosi, Giovanni
    Grabrucker, Andreas M.
    [J]. INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2017, 526 (1-2) : 413 - 424
  • [6] Challenges and opportunities in CNS delivery of therapeutics for neurodegenerative diseases
    Barchet, Thomas M.
    Amiji, Mansoor M.
    [J]. EXPERT OPINION ON DRUG DELIVERY, 2009, 6 (03) : 211 - 225
  • [7] The effect of nanoparticle size on the ability to cross the blood-brain barrier: an in vivo study
    Betzer, Oshra
    Shilo, Malka
    Opochinsky, Renana
    Barnoy, Eran
    Motiei, Menachem
    Okun, Eitan
    Yadid, Gal
    Popovtzer, Rachela
    [J]. NANOMEDICINE, 2017, 12 (13) : 1533 - 1546
  • [8] Blood-brain barrier models and their relevance for a successful development of CNS drug delivery systems: A review
    Bicker, Joana
    Alves, Gilberto
    Fortuna, Ana
    Falcao, Amilcar
    [J]. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2014, 87 (03) : 409 - 432
  • [9] Sonodynamic Therapy for Gliomas. Perspectives and Prospects of Selective Sonosensitization of Glioma Cells
    Bilmin, Krzysztof
    Kujawska, Tamara
    Grieb, Pawel
    [J]. CELLS, 2019, 8 (11)
  • [10] The road to restoring neural circuits for the treatment of Alzheimer's disease
    Canter, Rebecca G.
    Penney, Jay
    Tsai, Li-Huei
    [J]. NATURE, 2016, 539 (7628) : 187 - 196